Coherus Oncology (CHRS) Other financing activities (2014 - 2026)

Coherus Oncology (CHRS) posted Other financing activities of $52000.0 for Q1 2026, down 95.69% sequentially from $1.2 million in Q4 2025.

Coherus Oncology (CHRS) Other financing activities (2014 - 2026) Analysis & Trends

Coherus Oncology has reported Other financing activities for 13 years, with the latest figure at $52000.0 in Q1 2026.

Quarterly Other financing activities changed N/A year-over-year to $52000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $217000.0 (changed N/A YoY) and the FY2025 annual result came in at $353000.0, up 720.93% from the prior year.
Other financing activities retreated to $52000.0 in Q1 2026 per CHRS's latest filing, from $1.2 million in the prior quarter.
Over five years, Other financing activities peaked at $3.2 million in Q4 2022 and troughed at -$2.5 million in Q3 2022.
A 5-year average of $251846.2 and a median of $52000.0 in 2026 frame the typical range for Other financing activities.
The sharpest annual moves came in 2022 and 2025: Other financing activities soared 147.31% in 2022, then tumbled 14785.71% in 2025.
Over 5 years, Other financing activities stood at $3.2 million in 2022, then slumped by 120.21% to -$643000.0 in 2023, then surged by 98.91% to -$7000.0 in 2024, then soared by 17342.86% to $1.2 million in 2025, then slumped by 95.69% to $52000.0 in 2026.
According to Business Quant data, Other financing activities over the past three periods registered $52000.0, $1.2 million, and -$1.0 million for Q1 2026, Q4 2025, and Q3 2025 respectively.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)
1	Vertex Pharmaceuticals	139.13 Bn	131.28 Bn	2.84 Bn
2	Regeneron Pharmaceuticals	85.77 Bn	77.77 Bn	3.93 Bn
3	Argenx Se	64.64 Bn	59.46 Bn	1.37 Bn
4	Moderna	58.29 Bn	53.16 Bn	52.00 Mn
5	BeOne Medicines	41.92 Bn	36.82 Bn	1.53 Bn
6	Alnylam Pharmaceuticals	31.58 Bn	28.28 Bn	992.69 Mn
7	BioNTech SE	28.12 Bn	9.73 Bn	668.28 Mn
8	Insmed	27.39 Bn	26.22 Bn	358.27 Mn
9	Royalty Pharma	27.27 Bn	26.43 Bn	-
10	Coherus Oncology	221.39 Mn	116.08 Mn	10.07 Mn

Download Data